Home > Category > Signaling Pathways > Microbiology/Virology > HIV Protease > Darunavir (TMC114)

Darunavir (TMC114)

ChemLeader 98+%

Catalog No：CL2205 CAS No.：206361-99-1 MDLNo： Formula：C₂₇H₃₇N₃O₇S MW：547.66

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
200 mg	In-stock	$260.00	Visible after login	- +
500 mg	In-stock	$350.00	Visible after login	- +
1 g	In-stock	$450.00	Visible after login	- +
5 g	In-stock	$2500.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Darunavir (TMC114)
CAS	206361-99-1
Formula	C₂₇H₃₇N₃O₇S
MW	547.66
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions and also inhibits the dimerization of HIV-1 protease suppressing proteolytic activity and subsequent replication of HIV-1. Study results have shown that darunavir exhibits potent inhibition against HIV-1 with a value of 50% inhibition concentration IC50 of 0.003 μmol/L in HIV-1 infected MT-2 cells. Darunavir binds to HIV-1 protease with considerably high affinity and fits closely with the substrate envelop leading to its potent ability to inhibit multidrug-resistant HIV strains. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2205

Darunavir (TMC114)

206361-99-1 98+%